Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage

Digestive and Liver Disease

Volumn 42, Issue 3, 2010, Pages 200-204

  Cariello, Rita ^a   Federico, Alessandro ^a   Sapone, Anna ^a   Tuccillo, Concetta ^a   Scialdone, Valeria Rita ^a   Tiso, Angelo ^a   Miranda, Agnese ^a   Portincasa, Piero ^b   Carbonara, Veronica ^b   Palasciano, Giuseppe ^b   Martorelli, Luigi ^a   Esposito, Pasquale ^a   Cartenì, Maria ^a   Del Vecchio Blanco, Camillo ^a   Loguercio, Carmela ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Alcohol; Chronic liver damage; Cytokines; Intestinal permeability; Nitric oxide

Indexed keywords

INTERLEUKIN 6; NITRITE; S NITROSOTHIOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA PERMEABILITY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; ALCOHOLISM; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; HEPATITIS, CHRONIC; HUMANS; HYPERTENSION, PORTAL; INTERLEUKIN-6; INTESTINAL ABSORPTION; LACTULOSE; LIVER CIRRHOSIS; MALE; MANNITOL; MIDDLE AGED; NITRITES; S-NITROSOTHIOLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76049103019     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.05.001     Document Type: Article

References (47)

1. Loguercio C., De Simone T., Federico A., Terracciano F., Tuccillo C., Di Chicco M., et al. Gut-liver axis: a new point of attack to treat chronic liver damage?. Am J Gastroenterol 97 (2002) 2144-2146
2. Kim J.W., Jeon W.K., Yun J.W., Park D.I., Cho Y.K., Sung I.K., et al. Intestinal permeability in patients with viral and alcoholic liver disease. Korean J Gastroenterol 43 (2004) 104-111
3. Ancel D., Barraud H., Peyrin-Biroulet L., and Bronowicki J.P. Intestinal permeability and cirrhosis. Gastroenterol Clin Biol 30 (2006) 460-468
4. Astaldi G., and Strosselli E. Peroral biopsy of the intestinal mucosa in hepatic cirrhosis. Am J Dig Dis 5 (1960) 603-612
5. Such J., Guardiola J.V., deJuan J., Casellas J.A., Pascual S., Aparicio J.R., et al. Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur J Gastroenterol Hepatol 14 (2002) 371-376
6. Zuckerman M.J., Menzies I.S., Ho H., Gregory G.G., Casner N.A., Crane R.S., et al. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 49 (2004) 621-626
7. Rao R.K., Seth A., and Sheth P. Recent advances in alcoholic liver disease. I. Role of intestinal permeability and endotoxiemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 286 (2004) G881-G884
8. Xu W.H., Wu X.J., and Li J.S. Influence of portal pressure change on intestinal permeability in patients with portal hypertension. Hepatobiliary Pancreat Dis Int 1 (2002) 510-514
9. Rasaratnam B., Connelly N., and Chin-Dusting J. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?. Clin Sci 107 (2004) 425-434
10. Portincasa P., Grattagliano I., Palmieri V.O., and Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 38 (2005) 203-217
11. Cortez-Pinto H., Carneiro de Moura M., and Day C.P. Non alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44 (2006) 197-208
12. Loguercio C., Federico A., Tuccillo C., Terracciano F., D'Auria M.V., De Simone C., et al. Beneficial effects of a probiotic VSL(3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39 (2005) 540-543
13. Solga S.F., and Diehl A.M. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol 38 (2003) 681-687
14. Beer-Borst S., Morabia A., Hercberg S., Vitek O., Bernstein M.S., Galan P., et al. Obesity and other health determinants across Europe: the EURALIM project. J Epidemiol Community Health 54 (2000) 424-430
15. Nair S., Cope K., Risby T.H., and Diehl A.M. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96 (2001) 1200-1204
16. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagous for bleeding oesophageal varices. Br J Surg 60 (1973) 646-6499
17. Ishak K., Baptista A., and Bianchi L. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
18. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 (2001) 3-16
19. Babor T.F., de la Fuente J.R., and Saunders J. The alcohol use disorders identification test: guidelines for use in primary health care (1989), World Health Organization AUDIT, Geneva
20. De Franchis R., and Dell'Era A. Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Pract Res Clin Gastroenterol 21 (2007) 3-18
21. Thuluvath P.J., and Yoo H.Y. Portal hypertensive gastropathy. Am J Gastroenterol 97 (2002) 2973-2978
22. Generoso M., De Rosa M., De Rosa R., De Magistris L., Secondulfo M., Fiandra R., et al. Cellobiose and lactulose coupled with mannitol and determined using íon-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability. J Chromatogr B: Anal Technol Biomed Life Sci 783 (2003) 349-357
23. Secondulfo M., Iafusco D., Carratù R., deMagistris L., Sapone A., Generoso M., et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type 1 diabetic patients. Dig Liver Dis 225 (2004) 1-11
24. Liu H., Zhang S., Yu A., Qu L., Zhao Y., Huang H., et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett 14 (2004) 2339-2344
25. Parrilli G., Cuomo R., Nardone G., Maio G., Izzo C.M., and Budillon G. Investigation of intestine function during acute viral hepatitis using combined sugar oral loads. Gut 28 (1987) 1439-1444
26. Ersoz G., Aydin A., Erdem S., Yüksel D., Akarca U., and Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 11 (1999) 409-412
27. Campillo B., Pernet P., Bories P.N., Richardet J.P., Devanlay M., and Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 11 (1999) 755-759
28. Pascual S., Such J., Esteban A., Zapater P., Casellas J.A., and Aparicio J.R. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterol 50 (2003) 1482-1486
29. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
30. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and (15N) nitrate in biological fluids. Ann Biochem 126 (1982) 131-138
31. Federico A., Filippelli A., Falciani M., Tuccillo C., Tiso A., Floreani A., et al. Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies. World J Gastroenterol 13 (2007) 3677-3683
32. Klindbaum D.G., Kupper I.L., and Chambless L.E. Logistic regression analysis of epidemiological data. Theory and practice. Commun Stat Theory Methods 71 (1982) 485-541
33. Adam J.M., and Tarigan N.P. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening. Acta Med Indones 36 (2004) 3-7
34. Dastych M., Dastych Jr. M., Novotnà H., and Cíhalová J. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig Dis Sci 7 (2007) 184-188
35. Yao G.X., Shen Z.Y., Xue X.B., and Yang Z. Intestinal permeability in rats with CCl4-induced portal hypertension. World J Gastroenterol 12 (2006) 479-481
36. Kalaitzakis E., Johansson J.E., Bjarnason I., and Björnsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 41 (2006 Mar) 326-330
37. Hashimoto N., and Ohyanagi H. Effect of acute portal hypertension on gut mucosa. Hepatogastroenterology 49 (2002) 1567-1570
38. Fujii T., Seki T., Maruoka M., Tanaka J., Kawashima Y., Watanabe T., et al. Lactulose-l-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 19 (2001) 158-169
39. Lumeng L., and Crabb D.W. Alcoholic liver disease. Curr Opin Gastroenterol 16 (2000) 208-218
40. Ferrier L., Berard F., Debrauwer L., Chabo C., Langella P., Buéno L., et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol 168 (2006) 1148-1154
41. Bode C., and Bode J.C. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?. Alcohol Clin Exp Res 29 (2005) S166-S171
42. Guarner C., and Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 17 (2005) 27-31
43. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
44. Nanji A.A., Khrttry U., and Sardzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol Med 205 (1994) 243-247
45. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., and Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis. Gut 48 (2001) 206-211
46. Parlesak A., Schafer C., Schutz T., Bode J.C., and Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32 (2000) 742-747
47. Farrell G., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) 99-112